Toxoplasma IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
09-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
DiaSorin Australia Pty Ltd
Class:
Class 3
Manufactured by:
DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy
Therapeutic area:
CT820 - Toxoplasma IVDs
Therapeutic indications:
In vitro diagnostic assays for the determination of antibodies to Toxoplasma gondii in human samples.
Authorization status:
A
Authorization date:
2014-02-20
